Close Menu

Akonni

Funding Update for Jan 3, 2011

Premium

NSF Microarray Grants Awarded Aug. 1, 2010 — Jan. 1, 2011

Akonni will evaluate a method of manufacturing microarrays that it believes could lower the cost of array-based molecular diagnostic testing.

Akonni will use the grant to evaluate lab-on-a-film microarray manufacturing and assembly methods.

The company, which has received a number of government grants in recent months, has raised $912,598 in the round so far.

The grants, awarded through the Qualifying Therapeutic Discovery Project Program created by the Patient Protection and Affordable Care Act of 2010, were disclosed last week by the IRS.

Akonni Biosystems is developing a microarray-based SNP test for identifying physical appearance characteristics based on DNA samples from victims or suspects.

Akonni is developing a microarray-based transportable, sample-to-answer system for identifying single nucleotide polymorphisms linked to a person's physical appearance.

A company official said that Akonni's technology, which combines the power of real-time PCR interrogation with microarray analysis, is well-suited to address the emergence of drug resistance and the need to interrogate a broader range of markers in infectious disease.

Akonni is developing a multi-drug resistant/extensively drug-resistant (MDR/XDR) genotyping testing technology for the point-of-care setting.

Frederick, Md.-based Akonni plans to use the funding to support the development of its prototype MDR-TB PCR TruArray by expanding test coverage, completing the manufacturing scale-up for future kits, and performing pre-clinical verification experiments.

Pages

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.